Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers
about
Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Intranasal buprenorphine alone ...... cally dependent opioid abusers
@ast
Intranasal buprenorphine alone ...... cally dependent opioid abusers
@en
type
label
Intranasal buprenorphine alone ...... cally dependent opioid abusers
@ast
Intranasal buprenorphine alone ...... cally dependent opioid abusers
@en
prefLabel
Intranasal buprenorphine alone ...... cally dependent opioid abusers
@ast
Intranasal buprenorphine alone ...... cally dependent opioid abusers
@en
P2093
P2860
P1476
Intranasal buprenorphine alone ...... cally dependent opioid abusers
@en
P2093
Michelle R Lofwall
Paul A Nuzzo
Shanna Babalonis
Sharon L Walsh
Victoria Casselton
P2860
P304
P356
10.1016/J.DRUGALCDEP.2016.03.005
P577
2016-03-14T00:00:00Z